Top Markets
Coin of the day
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
株式のランク #30348
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
株価
$0.93298493
時価総額
$17.19M
変化(1日)
-1.38%
変化(1年)
-62.47%
JP
取引 Perseus Proteomics Inc. (4882)

カテゴリー

Perseus Proteomics Inc.(4882)の株式分割履歴
Perseus Proteomics Inc.株(シンボル:4882)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 19, 2026に行われました。
Aug 19, 2026より前に購入された4882株は、現在04882株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US